RecruitingPhase 1NCT06283355

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Comparing Single Versus Repeat Parent-to-Child Nasal Microbiome Transplant on Seeding, Engraftment, and Diversity of the Neonatal Nasal Microbiome

Sponsor

Johns Hopkins University

Enrollment

175 participants

Start Date

Sep 3, 2024

Study Type

INTERVENTIONAL

Conditions

Staphylococcus Aureus Microbial Colonization Neonatal Infection

Summary

This study aims to determine whether a parent-to-child nasal microbiota transplant (NMT) can seed and engraft parental organisms into the neonatal microbiome and increase the neonatal microbiome diversity.

Eligibility

Min Age: 0 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Nasal Microbiota Transplant (NMT) and a biological treatment called Placebo for people with microbial colonization, neonatal infection, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.